Biological and Clinical Database for Pancreatic Adenocarcinoma

Pancreatic cancer, specifically pancreatic adenocarcinoma, is a serious illness, being one of the leading causes of cancer death in Western countries. Unfortunately, it's often diagnosed at a late stage, and surgery, which is the best chance for a cure, is only possible for a small number of patients. Also, it's difficult to prevent or screen for because we don't have clear warning signs or reliable tests.

This project, called BACAP, aims to tackle these challenges. It's creating a special collection, often called a biobank, of biological samples (like blood, saliva, and tissue from tumors) and detailed medical information from patients with pancreatic cancer. This isn't just any collection; it's being built to the highest quality standards across many hospitals in France. The researchers hope that by studying these samples, along with the patients' health information, they can identify new patterns and 'markers' that will help diagnose the cancer earlier and develop more effective treatments.

A key part of this project is collecting various types of samples, including tumor tissue from surgeries and also from specific biopsies taken using a technique called endoscopic ultrasonography. This allows them to get samples even from tumors that can't be surgically removed. All the valuable DNA and RNA from these samples will be used for detailed molecular analyses. This whole effort is about accelerating research and finding better ways to help people with pancreatic cancer.